Alpha-Ammonium Carbamates Undergo Efficient Two-Step Linker Cleavage and Improve the Properties of Antibody Conjugates

Martin Schnermann,Xiaoyi Li,Nimit Patel,Joseph Kalen

DOI: https://doi.org/10.26434/chemrxiv-2024-5db77

2024-06-06

Abstract:Targeted payload delivery strategies, such as antibody-drug conjugates (ADCs), have emerged as useful therapeutics. Although considerable efforts have been made in the areas of antibody engineering and labeling methodology, improving the overall physicochemical properties of the linker/payload combination remains an important challenge. Here we report an approach to create an intrinsically polar linker domain. We find that -ammonium carbamates (AAC) undergo a tandem 1,6–1,2 elimination sequence to release secondary amines. Using a fluorogenic hemicyanine as a model payload component, we show that a zwitterionic AAC linker improves labeling efficiency and reduces antibody aggregation when compared to a commonly used Val-Ala linker as well as a cationic AAC. Cellular and in vivo fluorescence imaging studies demonstrate that the model payload is released in antigen-expressing cells and tumors with high specificity. Broadly, this strategy may provide a general approach to mask the hydrophobicity of payloads and improve the properties of targeted agents.

Chemistry

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the overall physicochemical properties of antibody - drug conjugates (ADCs), especially by designing an intrinsically polar linker domain to enhance the performance of ADCs. Specifically, the authors developed a two - step elimination sequence strategy based on α - ammonium carbamates (AAC) to create a zwitterionic linker, which can improve the labeling efficiency, reduce antibody aggregation, and show the ability to release the payload with high specificity in cell and in vivo fluorescence imaging studies.

### Main research questions:
1. **Improve the overall physicochemical properties of ADCs**: Existing ADC linkers are usually hydrophobic, which can lead to non - specific uptake and toxicity problems. The authors hope to improve the physicochemical properties of ADCs by designing a zwitterionic linker to mask the hydrophobicity of the payload.
2. **Increase the labeling efficiency**: Traditional linkers (such as Val - Ala linkers) may cause antibody aggregation during the labeling process, reducing the labeling efficiency. The authors hope to develop a new linker that can increase the labeling efficiency without sacrificing antibody performance.
3. **Achieve specific payload release**: The authors hope to achieve highly specific delivery to target cells or tumors by designing a payload release mechanism that can be triggered under specific conditions (such as enzyme - catalyzed or hypoxic environments).

### Specific methods and techniques:
- **Two - step elimination sequence**: The authors found that α - ammonium carbamates (AAC) can release secondary amines through a 1,6 - 1,2 elimination sequence. This chemical reaction was used to design a new linker.
- **Model payload**: Use far - infrared hemicyanine as a model payload component to verify the linker design through fluorescence imaging technology.
- **Cell and in vivo experiments**: Through cell experiments and mouse models, the performance of the new linker in terms of labeling efficiency, antibody aggregation, payload release specificity, etc. was evaluated.

### Experimental results:
- **Labeling efficiency and antibody aggregation**: Compared with the commonly used Val - Ala linker and cationic AAC, the zwitterionic AAC linker significantly improved the labeling efficiency and reduced antibody aggregation.
- **Payload release specificity**: Cell and in vivo fluorescence imaging studies showed that the model payload achieved highly specific release in antigen - expressing cells and tumors.
- **Overall physicochemical properties**: The zwitterionic AAC linker increased the overall hydrophilicity of ADCs and reduced non - specific uptake, especially non - specific uptake in the liver.

In general, this paper proposes a new linker design strategy aimed at improving the overall physicochemical properties of ADCs and enhancing their safety and effectiveness in treatment.